pharmaceuticals

Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY22 Earnings Concall dated Feb. 11, 2022 Corporate Participants: M. Satish Choudhury -- Company Secretary and…

Piramal Enterprises Ltd (NSE : PEL) Q3 FY22 Earnings Concall dated  Feb. 10, 2022, Corporate Participants: Hitesh Dhaddha -- Chief…

https://www.youtube.com/watch?v=Wh0LRTM3LTg Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Management Update: In financial service, PEL said it…

Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department…

https://www.youtube.com/watch?v=wOzoHVd4itc Key highlights from Jubilant Pharmova Limited (JUBLPHARMA) Q3 FY22 Earnings Concall Management Update: JUBLPHARMA stated that its performance during…

https://www.youtube.com/watch?v=3zJcH6WS7Fo Key highlights from Caplin Point Laboratories Ltd (CAPPL) Q3 FY22 Earnings Concall Management Update: In Caplin Steriles, CAPPL stated…

Cadila Healthcare Limited  (NSE:CADILAHC) Q3 FY22 Earnings Concall dated Feb. 03, 2022 Corporate Participants: Ganesh Nayak -- Executive Sharvil P.…

Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY22 Earnings Concall dated Jan. 31, 2022 Corporate Participants: Nimish Desai -- Head of Investor…

Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a…

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY22 Earnings Concall dated Jan. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and Chief…